Veterinary Medicines

Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves

Not authorised
  • Spectinomycin sulfate tetrahydrate
  • Lincomycin hydrochloride
Download as PDF

Product identification

Medicine name:
Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves
Linspec 50/100 mg/ml oldatos injekció kutyák,macskák,sertések és kifejlett bendőflórával nem rendelkező borjak részére
Active substance:
  • Spectinomycin sulfate tetrahydrate
  • Lincomycin hydrochloride
Target species:
  • Cattle
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Spectinomycin sulfate tetrahydrate
    151.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin hydrochloride
    54.49
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Hungary
Package description:
  • 250 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vials is placed in an outer container (paper box).
  • 100 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vial is placed in an outer container (paper box).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cenavisa S.L.
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 3232/X/12 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0238/001
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."